English | 简体中文 | 繁體中文 | 한국어 | 日本語
2020年9月22日 7時50分 HKT/SGT
Share:
Avance Clinical Announces Expanded eClinical Solutions for Biotech Clinical Trials at BioPharm America

ADELAIDE, AU, 2020年9月22日 - (JCN Newswire) - The leading Australian CRO for biotechs, and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner, Avance Clinical has expanded its eClinical solutions offering, with advanced digital clinical tools for enhanced patient engagement, visibility, data capture, and analysis. www.avancecro.com/eclinical-solutions

Avance Clinical made the announcement at BioPharm America (September 21-24, 2020)

Avance Clinical's biotech clients now have the option to deploy the latest eClinical solutions to maximise the value of study data and deliver real-time visibility on study progress.

Avance Clinical CEO Yvonne Lungershausen said:
"Our Data Management team works with eClinical leaders such as Medrio to offer regulatory compliant and patient centric tools for rapid start-up and continual data flow. These tools improve patient engagement and data collection and allow Sponsors to stay informed at every step with Sponsor visible portals."

The Avance Clinical eClinical services include the following:

eSource
- Direct data capture of source data on site
- Forms customised by Avance Clinical Data Management team
- Edit checks built into forms; instant firing of queries once data is entered
- Option for data to be collected off-line and synced when on-line is available
- Fully integrated with Medrio EDC, data visible for Sponsor review instantly
- Remote monitoring and data review on ongoing basis
- Avance Clinical provision of tablets if required

eConsent
- Electronic consent including patient sign-off and investigator confirmation
- Customisable to include animations, videos and questions as required
- Forms customised by Avance Clinical Data Management team
- Link via email to patient
- Compatible with any device and internet system (smart phones, tablet, laptop, desktop)
- Integrated with Medrio EDC
- Link can be shared with HREC as part of submission package

ePRO
- Electronic capture of patient reported outcome, including diary data, dosing compliance, questionnaires, VAS/Pain scales
- Forms customised by Avance Clinical Data Management team
- Link via email to patient
- Options for emails and reminders at set times during the day or week
- Timezone adjusted to patient's location
- Compatible with any device and internet system (smart phones, tablet, laptop, desktop)
- Fully integrated with Medrio EDC, data visible for Sponsor review instantly

Glynn Morrish, Avance Clinical Director Biometrics said:
"Direct electronic capture of study information and the complimentary suite of solutions offered by Avance Clinical allows the company and its clients to maximise clinical trial efficiency and flexibility while ensuring data integrity is preserved. Our highly trained and experienced biometrics team are excited to continue to work at the forefront of innovation and technology and provide services that offer stability and robustness to studies being conducted in an ever-changing global environment."

Avance Clinical is an Australian owned Contract Research Organisation that has been providing high-quality clinical research services fit for global regulatory standards to the local and international drug development industry for 20 years.

Considering Australia? Contact us about your next study. https://www.avancecro.com/eclinical-solutions/

About Avance Clinical www.avancecro.com

Australia's Avance Clinical has more than 20-years of experience and is now one of Australia's leading Contract Research Organizations.
Avance Clinical is committed to providing high-quality clinical research services with its highly-experienced team. The collective pool of knowledge and experience at Avance Clinical continually grows through the careful selection of experts who also demonstrate passion in their chosen field.
Avance Clinical offers high-quality services in an established clinical trial ecosystem, that includes world-class Investigators and Sites able to access specialized patient groups.
Other benefits include:
1. The Government R&D grant means up to 43.5% rebate on clinical trial spend
2. eClinical solutions - speed and continuity
3. Site Initiation Visit (SIV) and Study Start achieved in 5 - 6 weeks
4. No IND required for clinical trials
5. Full GMP material is not mandated for Phase I clinical trials
6. Established clinical trial environment with world-class Investigators and sites
7. Established healthy subject databases and specialized patient populations
8. Five independent Phase 1 facilities across Australia including hospital-based units for critical care
9. Major hospitals with world-class infrastructures and dedicated Clinical Trial Units with a long track-record in FDA compliant research
10. Seasonal studies: Northern hemisphere Sponsors can conduct their studies year-round by taking advantage of Australia's counter-flu and allergy seasons

Media Contact:
[email protected]
Chris Thompson

トピック: Press release summary

http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2020 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Global Coalition for Adaptive Research・アムジェン・エーザイ、COVID-19グローバル試験に最初の患者様が登録されたことを発表 
Oct 27, 2020 09:00 HKT/SGT
日立、ニューノーマルにおける新たな働き方の実現に向けてハンコレス/ペーパーレス・オフィス改革を推進 
Oct 26, 2020 15:00 HKT/SGT
横浜国立大・相鉄バス・NEC、車内混雑状況を可視化したバス運行情報アプリ「YNUダイナミックバスマップ」の試験公開 
Oct 26, 2020 13:00 HKT/SGT
KDDIとNEC、固定通話の事業者間IP接続に向け、オープンソースの仮想ネットワーク管理機能を開発 
Oct 26, 2020 10:00 HKT/SGT
NECとFC今治、サッカー指導法「OKADA METHOD」を取り入れたスポーツ育成支援プラットフォームを共同開発 
Oct 26, 2020 10:00 HKT/SGT
エーザイ、Cogstate社のデジタル認知機能評価技術の開発権と商業化権に関する契約をグローバルに拡大することに合意 
Oct 26, 2020 10:00 HKT/SGT
“台湾の秘密の花園”と呼ばれる台東の魅力を詰め込んだ,「台東旅行箱」in東京(10/24-26)開催! 
Oct 24, 2020 23:00 HKT/SGT
“台湾の秘密の花園”と呼ばれる台東の魅力を詰め込んだ,「台東旅行箱」in東京(10/24-26)開催! 
Oct 24, 2020 23:00 HKT/SGT
インフィニット エクスチェンジ(取引所)、間もなくスタート 
Oct 23, 2020 22:00 HKT/SGT
インフィニット エクスチェンジ(取引所)、間もなくスタート 
Oct 23, 2020 22:00 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8575